Table 3 Clinical outcomes per pathogen of 505 patients hospitalised with community-acquired pneumonia
Length of hospital stay (IQR) | ICU admission (%) | In-hospital mortality (%) | 30-day mortality (%) | One-year mortality (%) | |
|---|---|---|---|---|---|
Streptococcus pneumoniae (n = 124) | 8.5 (6.5-14.9) | 10 (8.1) | 4 (3.2) | 4 (3.2) | 12 (9.7) |
Coxiella burnetii (n = 28) | 5.5 (3.5-7.5) | 0 | 0 | 1 (3.6) | 1 (3.6) |
Haemophilus Influenzae (n = 27) | 9.0 (7.5-14.0) | 2 (7.4) | 0 | 0 | 3 (11.1) |
Legionella pneumophila (n = 20) | 11.0 (6.5-17.0) | 3 (15.0) | 1 (5.0) | 1 (5.0) | 2 (10.0) |
Chlamydophila species (n = 16) | 8.5 (6.6-13.3) | 2 (12.5) | 0 | 0 | 1 (6.3) |
Mycoplasma pneumoniae (n = 9) | 5.0 (4.5-7.3) | 0 | 0 | 0 | 0 |
Staphylococcus aureus (n = 9) | 10.5 (7.3-14.5) | 1 (11.1) | 3 (33.3) | 3 (33.3) | 4 (44.4) |
Other pathogen (n = 27) | 8.0 (5.0-15.8) | 7 (25.9) | 2 (7.4) | 2 (7.4) | 9 (33.3) |
Viral pathogen (n = 35) | 8.5 (6.3-13.5) | 1 (2.9) | 2 (5.7) | 3 (8.6) | 6 (17.1) |
No pathogen found (n = 210) | 8.5 (5.5-12.6) | 12 (5.7) | 12 (5.7) | 12 (5.7) | 35 (16.7) |